Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy

Elena Biagini1, Paolo Spirito, Guido Rocchi

  • 1Institute of Cardiology, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

Insights

Restrictive left ventricular filling patterns in hypertrophic cardiomyopathy (HC) predict poor outcomes. This Doppler echocardiographic finding independently indicates a significantly higher risk of sudden cardiac death and HC-related mortality.

Area of Science:

  • Cardiology
  • Echocardiography
  • Cardiovascular Disease

Background:

  • Restrictive left ventricular (LV) filling patterns are known prognostic indicators in dilated cardiomyopathy.
  • The prognostic significance of restrictive LV filling in hypertrophic cardiomyopathy (HC) has not been systematically studied.

Purpose of the Study:

  • To investigate the prognostic implications of Doppler-determined restrictive LV filling patterns in patients with HC.
  • To assess the association between restrictive filling and clinical outcomes, including end-stage HC, sudden cardiac death, and HC-related death or heart transplantation.

Main Methods:

  • Prospective study of 239 consecutive HC patients with systematic Doppler LV filling measurements.
  • Analysis of restrictive filling pattern at initial evaluation and during follow-up.
  • Univariate and multivariate analyses incorporating established HC risk factors.

Main Results:

  • Restrictive LV filling was identified in 5.9% at baseline and developed in 9.2% during follow-up.
  • Patients with restrictive filling had a sixfold increased risk of developing end-stage HC (HR 6.25, p=0.003).
  • Restrictive filling independently predicted sudden cardiac events (HR 3.51, p=0.009) and HC-related death or heart transplantation (HR 3.54, p<0.001) over a median 9.7-year follow-up.

Conclusions:

  • The Doppler pattern of restrictive LV filling is a strong and independent predictor of adverse outcomes in HC.
  • This finding holds true regardless of other established markers for poor prognosis in hypertrophic cardiomyopathy.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...